The optimal therapeutic approach for WM patients is not currently established. The question of whether a combinatory (or synergistic) regimen to overcome resistance and allow for fixed- duration treatment will allow for deep/durable responses is being addressed in ongoing clinical trials.
Meletios A Dimopoulos, Efstathios Kastritis, Roger G. Owen, Robert A. Kyle, Ola Landgren, Enrica Morra, Xavier Leleu, Ramón García‐Sánz, Nikhil C. Munshi, Kenneth C. Anderson, Evangelos Terpos, Irene M. Ghobrial, Pierre Morel, David G. Maloney, Mathias Rummel, Véronique Leblond, Ranjana H. Advani, Morie A. Gertz, Charalampia Kyriakou, Sheeba K. Thomas, Bart Barlogie, Stephanie A. Gregory, Eva Kimby,
Meletios A Dimopoulos, Efstathios Kastritis, Roger G. Owen, Robert A. Kyle, Ola Landgren, Xavier Leleu, Nikhil C. Munshi, Kenneth C. Anderson, Irene M. Ghobrial, David G. Maloney, Ranjana H. Advani, Morie A. Gertz, Sheeba K. Thomas, Steven P. Treon
Discussion(0)
No comments yet. Be the first to comment.